SNCA and Parkinson disease: Elevated levels of α-synuclein encoded by the SNCA gene have been widely implicated in the pathogenesis of Parkinson’s disease (PD), and as such we thought that targeting SNCA expression levels could be an attractive neuroprotective strategy (Tagliafierro and Chiba-Falek, 2016).